AN OPEN-LABEL EXTENSION STUDY OF AMIKACIN LIPOSOME INHALATION SUSPENSION (ALIS) FOR TREATMENT-REFRACTORY LUNG DISEASE CAUSED BY MYCOBACTERIUM AVIUM COMPLEX (MAC)

被引：2
|
作者：
Winthrop, Kevin [1 ]
Morimoto, Kozo [1 ]
Castellotti, Paola Francesca [1 ]
Yim, Jae-Joon [1 ]
Ruoss, Stephen [1 ]
van Ingen, Jakko [1 ]
Coulter, Christopher [1 ]
Mange, Kevin [1 ]
Nezamis, James [1 ]
Griffith, David [1 ]
机构：
[1] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
来源：
CHEST | 2019年 / 156卷 / 04期
关键词：
D O I：
10.1016/j.chest.2019.08.224
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：146A / 147A
页数：2
相关论文
共 50 条
  • [1] EXTENSION STUDY OF AMIKACIN LIPOSOME INHALATION SUSPENSION (ALIS) FOR TREATMENT-REFRACTORY LUNG DISEASE CAUSED BY MYCOBACTERIUM AVIUM COMPLEX (MAC)
    Winthrop, Kevin
    Eagle, Gina
    Morimoto, Kozo
    Castellotti, Paola Francesca
    O'Donnell, Anne
    Ruoss, Stephen
    Aksamit, Timothy
    Nezamis, James
    Griffith, David
    [J]. CHEST, 2018, 154 (04) : 182A - 183A
  • [2] Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by Mycobacterium avium Complex (CONVERT)
    Griffith, David E.
    Eagle, Gina
    Thomson, Rachel
    Aksamit, Timothy R.
    Hasegawa, Naoki
    Morimoto, Kozo
    Addrizzo-Harris, Doreen J.
    O'Donnell, Anne E.
    Marras, Theodore K.
    Flume, Patrick A.
    Loebinger, Michael R.
    Morgan, Lucy
    Codecasa, Luigi R.
    Hill, Adam T.
    Ruoss, Stephen J.
    Yim, Jae-Joon
    Ringshausen, Felix C.
    Field, Stephen K.
    Philley, Julie V.
    Wallace, Richard J., Jr.
    van Ingen, Jakko
    Coulter, Chris
    Nezamis, James
    Winthrop, Kevin L.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 198 (12) : 1559 - 1569
  • [3] Amikacin Liposome Inhalation Suspension (ALIS) for Treatment-Refractory Mycobacterium Avium Complex (MAC) Lung Disease: Effect of Baseline Amikacin and Clarithromycin Susceptibility on Culture Conversion
    Winthrop, K. L.
    Flume, P. A.
    Thomson, R.
    Brown-Elliott, B. A.
    Wallace, R. J., Jr.
    Griffith, D. E.
    Pennings, L. J.
    Coulter, C.
    Syrmis, M.
    Pandey, S.
    Yuen, D.
    Mange, K.
    van Ingen, J.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [4] Randomized Phase 3 Trial of Amikacin Liposome Inhalation Suspension (ALIS) for Treatment-Refractory Nontuberculous Mycobacterial (NTM) Lung Disease Caused by Mycobacterium Avium Complex (MAC) in Adult Patients
    Griffith, D. E.
    Eagle, G.
    Thomson, R. M.
    Aksamit, T. R.
    Hasegawa, N.
    Morimoto, K.
    Addrizzo-Harris, D. J.
    O'Donnell, A. E.
    Marras, T. K.
    Flume, P. A.
    Loebinger, M. R.
    Morgan, L. C.
    Castellotti, P. F.
    Hill, A. T.
    Ruoss, S. J.
    Yim, J. J.
    Ringshausen, F. C.
    Field, S. K.
    Nezamis, J.
    Winthrop, K. L.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [5] Sustainability and Durability of Culture Conversion in Patients Receiving Amikacin Liposome Inhalation Suspension (ALIS) for Treatment-Refractory Mycobacterium Avium Complex Lung Disease (MAC-LD) in the CONVERT Study
    Griffith, D. E.
    Thomson, R.
    Addrizzo-Harris, D. J.
    Field, S. K.
    van Ingen, J.
    Wallace, R. J., Jr.
    Coulter, C.
    Mange, K.
    Nezamis, J.
    Winthrop, K. L.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [6] Amikacin Liposome Inhalation Suspension for Mycobacterium avium Complex Lung Disease A 12-Month Open-Label Extension Clinical Trial
    Winthrop, Kevin L.
    Flume, Patrick A.
    Thomson, Rachel
    Mange, Kevin C.
    Yuen, Dayton W.
    Ciesielska, Monika
    Morimoto, Kozo
    Ruoss, Stephen J.
    Codecasa, Luigi R.
    Yim, Jae-Joon
    Marras, Theodore K.
    van Ingen, Jakko
    Wallace, Richard J., Jr.
    Brown-Elliott, Barbara A.
    Coulter, Chris
    Griffith, David E.
    [J]. ANNALS OF THE AMERICAN THORACIC SOCIETY, 2021, 18 (07) : 1147 - 1157
  • [7] Amikacin Liposome Inhalation Suspension as a Treatment Option for Refractory Nontuberculous Mycobacterial Lung Disease Caused by Mycobacterium avium Complex
    Swenson, Colin
    Del Parigi, Angelo
    [J]. MAYO CLINIC PROCEEDINGS, 2020, 95 (01) : 201 - 202
  • [8] Open-Label Trial of Amikacin Liposome Inhalation Suspension in Mycobacterium abscessus Lung Disease
    Siegel, Sarah A. R.
    Griffith, David E.
    Philley, Julie V.
    Brown-Elliott, Barbara A.
    Brunton, Amanda E.
    Sullivan, Peter E.
    Fuss, Cristina
    Strnad, Luke
    Wallace Jr, Richard J.
    Winthrop, Kevin L.
    [J]. CHEST, 2023, 164 (04) : 846 - 859
  • [9] Amikacin liposome inhalation suspension as a treatment for patients with refractory mycobacterium avium complex lung infection
    Zhang, Yang
    Hill, Adam T.
    [J]. EXPERT REVIEW OF RESPIRATORY MEDICINE, 2021, 15 (06) : 737 - 744
  • [10] Amikacin Liposome Inhalation Suspension: A Review in Mycobacterium avium Complex Lung Disease
    Matt Shirley
    [J]. Drugs, 2019, 79 : 555 - 562
12345